BiotechTube

SNDX-6352 + Placebo

Phase 2Terminated
0 watching 0 views this week⚡ Active
47
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Coronavirus

Conditions

Coronavirus, COVID, ARDS, Cytokine Storm, Cytokine Release Syndrome

Trial Timeline

May 30, 2020 → Jul 13, 2020

NCT ID
NCT04415073

About SNDX-6352 + Placebo

SNDX-6352 + Placebo is a phase 2 stage product being developed by Syndax Pharmaceuticals for Coronavirus. The current trial status is terminated. This product is registered under clinical trial identifier NCT04415073. Target conditions include Coronavirus, COVID, ARDS.

Hype Score Breakdown

Clinical
17
Activity
12
Company
5
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT04415073Phase 2Terminated

Competing Products

20 competing products in Coronavirus

See all competitors
ProductCompanyStageHype Score
Isavuconazonium Injection [Cresemba] + PlaceboAstellas PharmaPhase 3
77
bamlanivimab 7000mg + BRII-196+BRII-198 + AZD7442 (IV) + AZD7442 (IM) + SNG001 + Camostat + BMS-986414 + BMS-986413 + SAB-185 (3,840 Units/kg) + SAB-185 (10,240 Units/kg) + CASIRIVIMAB + IMDEVIMAB + Placebo for Bamlanivimab 7000mg + Placebo for Bamlanivimab 700mg + Placebo for BRII-196+BRII-198 + Placebo for SNG001 + Placebo for Camostat + Placebo for SAB-185 (low dose) + Placebo for BMS-986414 + BMS-986413 + Placebo for AZD7442 (IV) + Placebo for AZD7442 (IM) + Placebo for SAB-185 (high dose) + bamlanivimab 700mgEli LillyPhase 2/3
65
EQ001 + EQ001 PlaceboBioconPhase 3
77
Mesenchymal stem cellRohto PharmaceuticalPhase 1
33
ABBV-47D11 + Placebo for ABBV-47D11 + ABBV-2B04 + Placebo for ABBV-2B04AbbViePhase 1
33
Ibrutinib + PlaceboAbbViePhase 2
52
600 mg AZD7442 IV + 600mg placebo IVAstraZenecaPhase 2
52
EVUSHELDAstraZenecaPre-clinical
23
AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061]) + AZD7442 (tixagevimab [AZD8895] + cilgavimab [AZD1061])AstraZenecaPhase 2
52
AZD7442 IM + Placebo IM + AZD7442 IM + Placebo IM + AZD7442 IV + Placebo IV + AZD7442 IV + Placebo IVAstraZenecaPhase 1
33
Molnupiravir + PlaceboMerckPhase 3
77
Molnupiravir + PlaceboMerckPhase 2/3
65
V590MerckPhase 1
33
Molnupiravir + PlaceboMerckPhase 2/3
65
V591MerckPhase 1/2
41
Efprezimod alfa + PlaceboMerckPhase 3
77
M5049 + M5049 + PlaceboMerckPhase 2
52
Molnupiravir + PlaceboMerckPhase 3
77
Frespaciguat + PlaceboMerckPhase 1
33
Canakinumab + PlaceboNovartisPhase 3
77

Other Products from Syndax Pharmaceuticals

Revumenib + Placebo + Intensive Chemotherapy RegimenPhase 3
72
entinostat + anastrozolePhase 2
47
AxatilimabPhase 2
47
EntinostatPhase 2
47
Entinostat + ErlotinibPhase 2
47